$-0.06 EPS Expected for OraSure Technologies, Inc. (OSUR)

April 17, 2018 - By Vivian Currie

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.18, from 1.01 in 2017Q3. It dived, as 45 investors sold OraSure Technologies, Inc. shares while 56 reduced holdings. 34 funds opened positions while 50 raised stakes. 53.79 million shares or 2.08% less from 54.93 million shares in 2017Q3 were reported.
Mason Street Advsrs Limited Company stated it has 0.01% in OraSure Technologies, Inc. (NASDAQ:OSUR). Millennium Management Ltd Com accumulated 1.62M shares. Arrowstreet Ltd Partnership accumulated 402,072 shares or 0.02% of the stock. Ny State Teachers Retirement Sys invested in 0% or 47,695 shares. 62,350 were reported by Comerica Natl Bank. State Bank Of Montreal Can stated it has 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). Blackrock Inc invested 0.01% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). Peak6 Limited Partnership reported 0% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). Los Angeles Cap & Equity Inc, a California-based fund reported 33,962 shares. 30,262 are owned by Domini Impact Investments Ltd Liability Corp. Laurion Capital L P stated it has 0.01% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR). Aqr Capital Mgmt Limited Liability Corporation owns 95,366 shares or 0% of their US portfolio. Bnp Paribas Arbitrage reported 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). Credit Suisse Ag accumulated 48,633 shares. California Pub Employees Retirement holds 167,370 shares.

Since February 15, 2018, it had 0 insider purchases, and 2 sales for $778,707 activity. The insider SMITH BRIAN sold 20,000 shares worth $359,460.

Analysts expect OraSure Technologies, Inc. (NASDAQ:OSUR) to report $-0.06 EPS on May, 2.They anticipate $0.27 EPS change or 128.57 % from last quarter’s $0.21 EPS. After having $0.12 EPS previously, OraSure Technologies, Inc.’s analysts see -150.00 % EPS growth. The stock increased 1.68% or $0.29 during the last trading session, reaching $17.59. About 219,959 shares traded. OraSure Technologies, Inc. (NASDAQ:OSUR) has risen 34.91% since April 17, 2017 and is uptrending. It has outperformed by 23.36% the S&P500.

OraSure Technologies, Inc. (NASDAQ:OSUR) Ratings Coverage

Among 3 analysts covering Orasure Technologies (NASDAQ:OSUR), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Orasure Technologies had 8 analyst reports since October 20, 2017 according to SRatingsIntel. The firm earned “Buy” rating on Monday, October 23 by Canaccord Genuity. The company was maintained on Wednesday, November 22 by Canaccord Genuity. Jefferies downgraded OraSure Technologies, Inc. (NASDAQ:OSUR) on Thursday, November 2 to “Hold” rating. The stock of OraSure Technologies, Inc. (NASDAQ:OSUR) has “Buy” rating given on Friday, February 2 by Canaccord Genuity. The stock of OraSure Technologies, Inc. (NASDAQ:OSUR) has “Hold” rating given on Tuesday, February 13 by Jefferies. The stock of OraSure Technologies, Inc. (NASDAQ:OSUR) has “Buy” rating given on Thursday, November 2 by Canaccord Genuity. As per Friday, October 20, the company rating was maintained by Jefferies.

OraSure Technologies, Inc., together with its subsidiaries, develops, makes, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company has market cap of $1.08 billion. It operates in two divisions, OSUR and DNAG. It has a 34.49 P/E ratio. The firm also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

OraSure Technologies, Inc. (NASDAQ:OSUR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: